Evidence-Based Recs Issued for Systemic Care in Psoriasis

This article originally appeared here.
Share this content:
Evidence-Based Recs Issued for Systemic Care in Psoriasis
Evidence-Based Recs Issued for Systemic Care in Psoriasis

THURSDAY, Dec. 18, 2014 (HealthDay News) -- For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy with minimized toxicity, according to research published online Dec. 17 in JAMA Dermatology.

April W. Armstrong, M.D., M.P.H., from the University of Colorado Denver, and colleagues conducted a systematic review to develop evidence-based, best-practice recommendations for combination therapy for appropriately selected patients with psoriasis. Group discussions and voting were employed by the Medical Board of the National Psoriasis Foundation.

The researchers found that there were few trials that assessed the efficacy and safety of combination therapy in moderate to severe psoriasis. Combining biologics, such as etanercept or adalimumab, with phototherapy reduced disease severity more than either agent alone. Etanercept and methotrexate were more effective in combination than as monotherapy. Compared with infliximab alone, the combination of infliximab and methotrexate resulted in greater efficacy. Etanercept dose could be reduced to maintain similar levels of efficacy with concomitant use of acitretin. Psoriasis flares could be controlled with short-term cyclosporine use combined with etanercept or adalimumab. The preferred order for combining a second modality with biologics was: biologic and methotrexate; biologic and acitretin combination; and biologic and phototherapy combination. Insufficient data were available for combining biologics with acitretin, cyclosporine, or a second biologic.

"Among appropriately selected patients with psoriasis, carefully chosen combinations may result in greater efficacy, while minimizing toxicity," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »